Serum lactate dehydrogenase level as a prognostic factor in Hodgkin's disease
- PMID: 8260377
- PMCID: PMC1968658
- DOI: 10.1038/bjc.1993.509
Serum lactate dehydrogenase level as a prognostic factor in Hodgkin's disease
Abstract
The efficacy of currently available treatments for Hodgkin's disease (HD) has led to a substantial modification in the prognosis of this disease; nevertheless there is still a group of patients that cannot be cured with conventional treatments and who will be candidates for alternative therapy. In the present work we analysed the prognostic influence of the most relevant clinico-biological characteristics of HD in a consecutive series of 137 patients diagnosed and treated in a single institution. Univariate analyses identified six variables with significant prognostic influence, both on achieving complete remission (CR) and overall survival (OS); LDH > 320 U ml-1, age > 45 years, stages IIB, III and IV, extranodal involvement, alkaline phosphatase > 190 UI dl and ESR > 40 mm h. In addition, Hb < 12.5 gr dl-1 and abdominal disease were statistically relevant for CR while a poor performance score (ECOG > or = 2) affected a lower survival. In the multivariate analysis only LDH, age and the clinical stage retained a significant prognostic influence for achieving CR, while the two first factors above, together with performance status were the variables with independent prognostic value with respect to OS. Moreover, only LDH > 320 U ml-1 had prognostic influence in the probability of relapse and disease free survival (DFS), both in the univariate and multivariate analyses. According to the three independent factors obtained in the multivariate analysis for CR (LDH, age and stage) a predictive model was established that allows the stratification of patients into two prognostic groups: one with poor prognosis that includes patients with the three adverse prognostic factors, or two if one of them was elevated LDH, and the other with good prognosis that includes the remaining patients. This model was also able to separate two independent groups of patients with respect to OS and to DFS. In conclusion, the present study shows that LDH is one of the most important prognostic factors in HD.
Similar articles
-
Diffuse large cell lymphomas: identification of prognostic factors and validation of the International Non-Hodgkin's Lymphoma Prognostic Index. A Hellenic Cooperative Oncology Group Study.Oncology. 1998 Sep-Oct;55(5):405-15. doi: 10.1159/000011886. Oncology. 1998. PMID: 9732217
-
[Clinical significance of erythrocyte sedimentation rate, C-reactive protein and serum lactate dehydrogenase levels in the diagnosis, prognosis and treatment monitoring of children suffering from cancer].Med Wieku Rozwoj. 2004 Oct-Dec;8(4 Pt 2):1081-9. Med Wieku Rozwoj. 2004. PMID: 15951603 Polish.
-
Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.Scand J Immunol. 2009 Nov;70(5):490-500. doi: 10.1111/j.1365-3083.2009.02313.x. Scand J Immunol. 2009. PMID: 19874554
-
Prognostic factors in Hodgkin's and non-Hodgkin's lymphomas.Curr Opin Oncol. 1991 Oct;3(5):843-51. doi: 10.1097/00001622-199110000-00007. Curr Opin Oncol. 1991. PMID: 1751578 Review.
-
Enzymes as prognostic markers and therapeutic indicators in patients with cancer.Clin Chim Acta. 1992 Mar 13;206(1-2):77-82. doi: 10.1016/0009-8981(92)90008-e. Clin Chim Acta. 1992. PMID: 1572080 Review.
Cited by
-
Serum macrophage colony-stimulating factor (M-CSF) in patients with Hodgkin lymphoma.Med Oncol. 2012 Sep;29(3):2143-7. doi: 10.1007/s12032-011-0010-1. Epub 2011 Jun 30. Med Oncol. 2012. PMID: 21717212
-
Investigation of NK cell function and their modulation in different malignancies.Immunol Res. 2012 Apr;52(1-2):139-56. doi: 10.1007/s12026-012-8285-7. Immunol Res. 2012. PMID: 22442005 Review.
-
Multivariate prognostic index and triplet regimen efficacy predictive index in locally advanced and metastatic gastric cancer: pooled analysis from three clinical trials using individual patient data.Ther Adv Med Oncol. 2024 Feb 27;16:17588359241233982. doi: 10.1177/17588359241233982. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38420603 Free PMC article.
-
Clinical Profile and Chemotherapy Response in Children with Hodgkin Lymphoma at a Tertiary Care Centre.J Clin Diagn Res. 2015 Nov;9(11):SC25-30. doi: 10.7860/JCDR/2015/14876.6845. Epub 2015 Nov 1. J Clin Diagn Res. 2015. PMID: 26674594 Free PMC article.
-
Elevated Lactate Dehydrogenase Levels Display a Poor Prognostic Factor for Non-Hodgkin's Lymphoma in Intensive Care Unit: An Analysis of the MIMIC-III Database Combined With External Validation.Front Oncol. 2021 Oct 28;11:753712. doi: 10.3389/fonc.2021.753712. eCollection 2021. Front Oncol. 2021. PMID: 34778068 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous